Login to Your Account

AACR 2012

No Easy Road, But a Map, from Genomes to Drug Combinations

By Anette Breindl
Science Editor

Wednesday, April 4, 2012

Buoyed by ever-faster sequencing abilities, scientists are making headway in understanding cancer genomics. But, William Sellers told the audience at the American Association of Cancer Research meeting this week, as impressive as genomic advances have been, "most known genetic alterations have not led directly to drug candidates."

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription